Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

New understanding of a decades-old bladder cancer treatment could help improve immunotherapies more broadly

New understanding of a decades-old bladder cancer treatment could help improve immunotherapies more broadly

ASCO 2025: New standard of care emerges for multiple myeloma

ASCO 2025: New standard of care emerges for multiple myeloma

ASCO 2025: Combination of encorafenib and cetuximab with chemo helps some advanced colorectal cancer patients live longer

ASCO 2025: Combination of encorafenib and cetuximab with chemo helps some advanced colorectal cancer patients live...

International cancer patient coalition champions patient access at ASCO 2025

International cancer patient coalition champions patient access at ASCO 2025

Global warming could be driving up women’s cancer risk

Global warming could be driving up women’s cancer risk

ASCO 2025: Immune checkpoint inhibitors ‘high-risk yet promising’ for cancer patients who undergo organ transplant

ASCO 2025: Immune checkpoint inhibitors ‘high-risk yet promising’ for cancer patients who undergo organ transplant

Dual action immunotherapy in CAR-T cells improves control of B-ALL progression

Dual action immunotherapy in CAR-T cells improves control of B-ALL progression

Stratifying the immune landscape of tongue cancer

Stratifying the immune landscape of tongue cancer

ASCO 2025: Treatment combination with inavolisib extends survival, delays chemotherapy for some patients with advanced breast cancer

ASCO 2025: Treatment combination with inavolisib extends survival, delays chemotherapy for some patients with...

ASCO 2025: Study demonstrates improved survival with combination of lurbinectedin and atezolizumab for extensive-stage small cell lung cancer

ASCO 2025: Study demonstrates improved survival with combination of lurbinectedin and atezolizumab for extensive...

More from ecancer